查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
南美洲和中美洲放射性药物治疗市场预测至 2028 年 - 区域分析 - 按产品类型、放射性同位素；来源、应用；指示和最终用户
市场调查报告书
商品编码
1402471

南美洲和中美洲放射性药物治疗市场预测至 2028 年 - 区域分析 - 按产品类型、放射性同位素；来源、应用；指示和最终用户

South & Central America Radiopharmaceutical Theranostics Market Forecast to 2028 - Regional Analysis - by Product Type, Radioisotope ; Source, Application ; Indication, and End User
出版日期: | 出版商: The Insight Partners | 英文 145 Pages | 订单完成后即时交付

价格

2022年，南美洲和中美洲放射性药物治疗诊断市场价值为1.2948亿美元，预计到2028年将达到2.3371亿美元；预计2022年至2028年CAGR为10.3%。

用于个人化放射性药物治疗的治疗诊断数位双胞胎推动了南美洲和中美洲放射性药物治疗市场

放射性药物治疗 (RPT) 涉及向所有接受治疗的患者註射特定的放射性药物（例如 Lu-177-PSMA 和 Lu-177-DOTATATE 的剂量为 200mCi）。然而，注射后，输送到器官的剂量和药物的吸收品质显示出显着的变化。肿瘤和正常组织的放射性药物治疗取决于吸收剂量；然而，吸收的变化很难控制。固定的给药剂量会导致患者治疗不足，可能导致剂量毒性病例。治疗诊断数位孪生 (TDT) 可用于药物开发过程以克服此类限制。 TDT 研究患者在註射部位的最佳注射放射性药物，并确定注射间隔和曲线，以及适当的组合放射性药物疗法。此外，TDT 与适当的计算工具相结合可用于预测吸收辐射剂量建模。此外，TDT 承诺所产生的临床结果为零不确定性，因此成为为患者提供真正个人化治疗的强大工具。因此，在个人化放射性药物治疗中使用 TDT 为放射性药物治疗诊断市场参与者提供了利润丰厚的机会。

南美洲和中美洲放射性药物治疗诊断市场概述

南美洲和中美洲的放射性药物治疗诊断市场分为阿根廷、巴西以及南美洲和中美洲的其他地区。该地区的市场成长归因于癌症和心血管疾病盛行率的增加以及政府支持计划的存在。容易患心血管疾病的糖尿病患者日益增多正在促进巴西放射性药物治疗市场的成长。此外，巴西不断扩大的医疗保健支出正在推动放射性药物治疗诊断市场的发展。

南美洲及中美洲放射性药物治疗市场收入及 2028 年预测（百万美元）

南美洲和中美洲放射性药物治疗诊断市场细分

南美洲和中美洲放射性药物治疗诊断市场根据产品类型、放射性同型、来源、应用、适应症、最终用户和国家进行细分。根据产品类型，南美洲和中美洲放射性药物治疗诊断市场分为 α 发射器、β 发射器和正子断层扫描 (PET) 示踪剂。 2022 年，正子断层扫描 (PET) 示踪剂领域占据最大的市场份额。

依放射性同型，南美洲和中美洲放射性药物治疗市场分为锝-99、镓-68、碘-131、碘-123、氟-18 (18F)、钇 90 (Y-90)、镥 (Lu) 177、铜(Cu) 67、铜(Cu) 64 等。镥 (Lu) 177 细分市场在 2022 年占据最大的市场份额。

根据消息来源，南美洲和中美洲的放射性药物治疗诊断市场分为核反应器和迴旋加速器。到 2022 年，迴旋加速器领域将占据更大的市场份额。

根据应用，南美洲和中美洲放射性药物治疗诊断市场分为标靶治疗 [Rx] 和伴随诊断 [CDx]。 2022 年，标靶治疗 [Rx] 细分市场占据了更大的市场份额。

根据指示，南美洲和中美洲放射性药物治疗诊断市场分为肿瘤学、心臟病学、神经学等。 2022 年，肿瘤学领域占据最大的市场。

根据最终用户，南美洲和中美洲放射性药物治疗诊断市场分为医院、诊断影像中心、学术和研究机构等。 2022 年，医院细分市场占据最大市场份额。

根据国家/地区，南美洲和中美洲放射性药物治疗诊断市场分为巴西、阿根廷以及南美洲和中美洲其他地区。 2022 年，巴西在南美洲和中美洲放射性药物治疗诊断市场份额中占据主导地位。

拜耳公司；锔; Telix 製药有限公司；和西门子 Healthineers 是南美洲和中美洲放射性药物治疗市场的一些领先公司。

目录

第 1 章：简介

  • 研究范围
  • Insight Partners 研究报告指南
  • 市场区隔
    • 南美洲和中美洲放射性药物治疗诊断市场 - 按产品类型
    • 南美洲和中美洲放射性药物治疗市场 - 按放射性同位素
    • 南美洲和中美洲放射性药物治疗诊断市场 - 按来源
    • 南美洲和中美洲放射性药物治疗诊断市场 - 按应用
    • 南美洲和中美洲放射性药物治疗诊断市场 - 按适应症分类
    • 南美洲和中美洲放射性药物治疗市场 - 按最终用户
    • 南美洲和中美洲放射性药物治疗市场 - 按国家/地区

第 2 章：南美洲和中美洲放射性药物治疗市场 - 要点

第 3 章：研究方法

  • 覆盖范围
  • 二次研究
  • 初步研究

第 4 章：南美洲和中美洲放射性药物治疗诊断市场 - 市场模式

  • 概述
  • PEST分析
    • 南美洲和中美洲 PEST 分析
  • 专家意见

第 5 章：南美洲和中美洲放射性药物治疗诊断市场 - 主要市场动态

  • 市场驱动因素
    • 癌症发生率上升
    • 在心血管疾病治疗的应用不断增加
  • 市场限制
    • 批准放射性药物治疗的监管挑战
  • 市场机会
    • 用于个人化放射性药物治疗的治疗诊断数位孪生
  • 未来的趋势
    • 核子医学中的放射性药物治疗诊断学
  • 影响分析

第 6 章：放射性药物治疗市场 - 南美洲和中美洲分析

  • 南美洲与中美洲放射性药物治疗市场收入预测与分析

第 7 章：南美洲和中美洲放射性药物治疗市场 - 收入和 2028 年预测 - 按产品类型

  • 概述
  • 2021 年和 2028 年按产品类型分類的放射性药物治疗市场收入份额 (%)

第 8 章：南美洲和中美洲放射性药物治疗市场分析 - 按放射性同位素

  • 概述
  • 2021 年和 2028 年放射性药物治疗市场收入份额（按放射性同位素划分）（%）

第 9 章：南美洲和中美洲放射性药物治疗市场分析 - 按来源

  • 概述
  • 2021 年及 2028 年放射性药物治疗市场收入份额（按来源划分）（%）

第 10 章：南美洲和中美洲放射性药物治疗市场分析 -按应用

  • 概述
  • 2021 年和 2028 年按应用分類的放射性药物治疗市场收入份额 (%)

第 11 章：南美洲和中美洲放射性药物治疗市场分析 - 按适应症

  • 概述
  • 2021 年和 2028 年按适应症分類的放射性药物治疗市场收入份额 (%)

第 12 章：南美洲和中美洲放射性药物治疗市场分析 - 按最终用户

  • 概述
  • 2021 年和 2028 年按最终用户分類的放射性药物治疗市场收入份额 (%)

第 13 章：南美洲和中美洲放射性药物治疗市场 - 收入和 2028 年预测 - 按国家分析

第 14 章：放射性药物治疗市场 - 产业格局

  • 概述
  • 放射性药物治疗市场的成长策略
  • 无机成长策略
    • 概述
  • 有机成长策略
    • 概述

第 15 章：公司简介

  • Bayer AG
  • Curium
  • Telix Pharmaceuticals Ltd.
  • Siemens Healthineers AG

第 16 章：附录

  • 关于 Insight Partners
  • 专业术语
Product Code: BMIRE00029008

The South & Central America radiopharmaceutical theranostics market was valued at US$ 129.48 million in 2022 and is expected to reach US$ 233.71 million by 2028; it is estimated to register a CAGR of 10.3% from 2022 to 2028.

Theranostic Digital Twins for Personalized Radiopharmaceutical Therapies fuel the South & Central America Radiopharmaceutical Theranostics Market

Radiopharmaceutical therapies (RPTs) involve injecting a particular radioactive drug (such as 200mCi for Lu-177-PSMA and Lu-177-DOTATATE) into all patients undergoing therapy. However, upon injection, the doses delivered to organs and absorbed qualities of drugs show notable variations. Radiopharmaceutical therapies for tumors and normal tissues depend on absorbed doses; however, variations in absorption are difficult to control. A fixed administered dosage results in the undertreatment of patients, possibly leading to cases of dose toxicity. Theranostic digital twins (TDTs) can be employed in the drug development process to overcome such limitations. The TDTs investigate optimal injected radioactive drugs among patients at the sites of injection, along with determining injection intervals and profiles, and suitable combinational radiopharmaceutical therapies. Additionally, TDTs coupled with appropriate computational tools can be used in predictive absorbed radiation dose modeling. Further, TDTs promise zero uncertainties in the clinical results generated, thus acting as a powerful tool for offering truly personalized treatments to patients. Thus, the use of TDTs in personalized radiopharmaceutical therapies provides lucrative opportunities for radiopharmaceutical theranostics market players.

South & Central America Radiopharmaceutical Theranostics Market Overview

The South & Central America radiopharmaceutical theranostics market is segmented into the Argentina, Brazil, and the rest of South & Central America. The market growth in this region is due to the increasing prevalence of cancer and cardiovascular diseases, and presence of supportive government plans. Growing diabetes who are prone to cardiovascular disease is promoting the growth of radiopharmaceutical theranostics market in Brazil. Further, expanding healthcare expenditure in Brazil is boosting the radiopharmaceutical theranostics market.

South & Central America Radiopharmaceutical Theranostics Market Revenue and Forecast to 2028 (US$ Million)

South & Central America Radiopharmaceutical Theranostics Market Segmentation

The South & Central America radiopharmaceutical theranostics market is segmented based on product type, radioisotype, source, application, indication, end user, and country. Based on product type, the South & Central America radiopharmaceutical theranostics market is segmented into alpha emitters, beta emitters, and Positron Emission Tomography (PET) tracers. The Positron Emission Tomography (PET) tracers segment held the largest market share in 2022.

Based on radioisotype, the South & Central America radiopharmaceutical theranostics market is segmented into technetium-99, gallium-68, iodine-131, iodine-123, Fluorine-18 (18F), Yttrium 90 (Y-90), Lutetium (Lu) 177, Copper (Cu) 67, Copper (Cu) 64, and others. The Lutetium (Lu) 177 segment held the largest market share in 2022.

Based on source, the South & Central America radiopharmaceutical theranostics market is bifurcated into nuclear reactors and cyclotrons. The cyclotrons segment held a larger market share in 2022.

Based on application, the South & Central America radiopharmaceutical theranostics market is bifurcated into targeted therapeutic [Rx] and Companion Diagnostic [CDx]. The targeted therapeutic [Rx] segment held a larger market share in 2022.

Based on indication, the South & Central America radiopharmaceutical theranostics market is segmented into oncology, cardiology, neurology, and others. The oncology segment held the largest market share in 2022.

Based on end user, the South & Central America radiopharmaceutical theranostics market is segmented into hospitals, diagnostic imaging centers, academic and research institutes, and others. The hospitals segment held the largest market share in 2022.

Based on country, the South & Central America radiopharmaceutical theranostics market is segmented into Brazil, Argentina, and the Rest of South & Central America. Brazil dominated the South & Central America radiopharmaceutical theranostics market share in 2022.

Bayer AG; Curium; Telix Pharmaceuticals Ltd.; and Siemens Healthineers are some of the leading companies operating in the South & Central America radiopharmaceutical theranostics market.

Reasons to Buy:

  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the South & Central Americaradiopharmaceutical theranostics market.
  • Highlights key business priorities in order to assist companies to realign their business strategies
  • The key findings and recommendations highlight crucial progressive industry trends in the South & Central Americaradiopharmaceutical theranostics market, thereby allowing players across the value chain to develop effective long-term strategies
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
  • Scrutinize in-depth South & Central America market trends and outlook coupled with the factors driving the South & Central Americaradiopharmaceutical theranostics market, as well as those hindering it
  • Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution

Table Of Contents

1. Introduction

  • 1.1 Scope of the Study
  • 1.2 The Insight Partners Research Report Guidance
  • 1.3 Market Segmentation
    • 1.3.1 South & Central America Radiopharmaceutical Theranostics Market - by Product Type
    • 1.3.2 South & Central America Radiopharmaceutical Theranostics Market - by Radioisotope
    • 1.3.3 South & Central America Radiopharmaceutical Theranostics Market - by Source
    • 1.3.4 South & Central America Radiopharmaceutical Theranostics Market - by Application
    • 1.3.5 South & Central America Radiopharmaceutical Theranostics Market - by Indication
    • 1.3.6 South & Central America Radiopharmaceutical Theranostics Market - by End User
    • 1.3.7 South & Central America Radiopharmaceutical Theranostics Market - by Country

2. South & Central America Radiopharmaceutical Theranostics Market - Key Takeaways

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. South & Central America Radiopharmaceutical Theranostics Market - Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis
    • 4.2.1 South & Central America PEST Analysis
  • 4.3 Expert's Opinion

5. South & Central America Radiopharmaceutical Theranostics Market - Key Market Dynamics

  • 5.1 Market Drivers
    • 5.1.1 Rising Incidence of Cancer
    • 5.1.2 Rising Application in Treatment of Cardiovascular Disorders
  • 5.2 Market Restraints
    • 5.2.1 Regulatory Challenges for Approval of Radiopharmaceutical Theranostics
  • 5.3 Market Opportunities
    • 5.3.1 Theranostic Digital Twins for Personalized Radiopharmaceutical Therapies
  • 5.4 Future Trends
    • 5.4.1 Radiopharmaceutical Theranostics in Nuclear Medicine
  • 5.5 Impact Analysis

6. Radiopharmaceutical Theranostics Market - South & Central America Analysis

  • 6.1 South & Central America Radiopharmaceutical Theranostics Market Revenue Forecast and Analysis

7. South & Central America Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 - by Product Type

  • 7.1 Overview
  • 7.2 Radiopharmaceutical Theranostics Market Revenue Share, by Product Type 2021 & 2028 (%)
    • 7.2.1 Positron Emission Tomography (PET) Tracers
      • 7.2.1.1 Overview
      • 7.2.1.2 Positron Emission Tomography (PET) Tracers: Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
    • 7.2.2 Beta Emitters
      • 7.2.2.1 Overview
      • 7.2.2.2 Beta Emitters: Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
    • 7.2.3 Alpha Emitters
      • 7.2.3.1 Overview
      • 7.2.3.2 Alpha Emitters: Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)

8. South & Central America Radiopharmaceutical Theranostics Market Analysis - by Radioisotope

  • 8.1 Overview
  • 8.2 Radiopharmaceutical Theranostics Market Revenue Share, by Radioisotope 2021 & 2028 (%)
    • 8.2.1 Technetium-99
      • 8.2.1.1 Overview
      • 8.2.1.2 Technetium-99: Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
    • 8.2.2 Gallium-68
      • 8.2.2.1 Overview
      • 8.2.2.2 Gallium-68: Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
    • 8.2.3 Iodine-131
      • 8.2.3.1 Overview
      • 8.2.3.2 Iodine-131: Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
    • 8.2.4 Iodine-123
      • 8.2.4.1 Overview
      • 8.2.4.2 Iodine-123: Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
    • 8.2.5 Fluorine-18 (18F)
      • 8.2.5.1 Overview
      • 8.2.5.2 Fluorine-18 (18F): Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
    • 8.2.6 Yttrium 90 (Y-90)
      • 8.2.6.1 Overview
      • 8.2.6.2 Yttrium 90 (Y-90): Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
    • 8.2.7 Lutetium (LU) 177
      • 8.2.7.1 Overview
      • 8.2.7.2 Lutetium (LU) 177: Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
    • 8.2.8 Copper (CU) 67
      • 8.2.8.1 Overview
      • 8.2.8.2 Copper (CU) 67: Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
    • 8.2.9 Copper (CU) 64
      • 8.2.9.1 Overview
      • 8.2.9.2 Copper (CU) 64: Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
    • 8.2.10 Others
      • 8.2.10.1 Overview
      • 8.2.10.2 Others: Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)

9. South & Central America Radiopharmaceutical Theranostics Market Analysis - by Source

  • 9.1 Overview
  • 9.2 Radiopharmaceutical Theranostics Market Revenue Share, by Source 2021 & 2028 (%)
    • 9.2.1 Nuclear Reactors
      • 9.2.1.1 Overview
      • 9.2.1.2 Nuclear Reactors: Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
    • 9.2.2 Cyclotrons
      • 9.2.2.1 Overview
      • 9.2.2.2 Cyclotrons: Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)

10. South & Central America Radiopharmaceutical Theranostics Market Analysis - by Application

  • 10.1 Overview
  • 10.2 Radiopharmaceutical Theranostics Market Revenue Share, by Application 2021 & 2028 (%)
    • 10.2.1 Targeted Therapeutic (Rx)
      • 10.2.1.1 Overview
      • 10.2.1.2 Targeted Therapeutics (Rx): Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
    • 10.2.2 Companion Diagnostic (CDx)
      • 10.2.2.1 Overview
      • 10.2.2.2 Companion Diagnostics (CDx): Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)

11. South & Central America Radiopharmaceutical Theranostics Market Analysis - by Indication

  • 11.1 Overview
  • 11.2 Radiopharmaceutical Theranostics Market Revenue Share, by Indication 2021 & 2028 (%)
    • 11.2.1 Oncology
      • 11.2.1.1 Overview
      • 11.2.1.2 Oncology: Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
    • 11.2.2 Neurology
      • 11.2.2.1 Overview
      • 11.2.2.2 Neurology: Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
    • 11.2.3 Cardiology
      • 11.2.3.1 Overview
      • 11.2.3.2 Cardiology: Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
    • 11.2.4 Others
      • 11.2.4.1 Overview
      • 11.2.4.2 Others: Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)

12. South & Central America Radiopharmaceutical Theranostics Market Analysis - by End User

  • 12.1 Overview
  • 12.2 Radiopharmaceutical Theranostics Market Revenue Share, by End User 2021 & 2028 (%)
    • 12.2.1 Hospitals
      • 12.2.1.1 Overview
      • 12.2.1.2 Hospitals: Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
    • 12.2.2 Diagnostic Imaging Centers
      • 12.2.2.1 Overview
      • 12.2.2.2 Diagnostic Imaging Centers: Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
    • 12.2.3 Academic & Research Institutes
      • 12.2.3.1 Overview
      • 12.2.3.2 Academic & Research Institutes: Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
    • 12.2.4 Others
      • 12.2.4.1 Overview
      • 12.2.4.2 Others: Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)

13. South & Central America Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 - by Country Analysis

  • 13.1 South & Central America Radiopharmaceutical Theranostics Market
    • 13.1.1 Overview
    • 13.1.2 South & Central America: Radiopharmaceutical Theranostics Market, by Country, 2021 & 2028 (%)
      • 13.1.2.1 Brazil: Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
        • 13.1.2.1.1 Overview
        • 13.1.2.1.2 Brazil Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
        • 13.1.2.1.3 Brazil Radiopharmaceutical Theranostics Market, by Product type, 2019-2028 (US$ Million)
        • 13.1.2.1.4 Brazil Radiopharmaceutical Theranostics Market, by Radioisotope, 2019-2028 (US$ Million)
        • 13.1.2.1.5 Brazil Radiopharmaceutical Theranostics Market, by Source, 2019-2028 (US$ Million)
        • 13.1.2.1.6 Brazil Radiopharmaceutical Theranostics Market, by Application, 2019-2028 (US$ Million)
        • 13.1.2.1.7 Brazil Radiopharmaceutical Theranostics Market, by Indication, 2019-2028 (US$ Million)
        • 13.1.2.1.8 Brazil Radiopharmaceutical Theranostics Market, by End User, 2019-2028 (US$ Million)
      • 13.1.2.2 Argentina: Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
        • 13.1.2.2.1 Overview
        • 13.1.2.2.2 Argentina Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
        • 13.1.2.2.3 Argentina Radiopharmaceutical Theranostics Market, by Product Type, 2019-2028 (US$ Million)
        • 13.1.2.2.4 Argentina Radiopharmaceutical Theranostics Market, by Radioisotope, 2019-2028 (US$ Million)
        • 13.1.2.2.5 Argentina Radiopharmaceutical Theranostics Market, by Source, 2019-2028 (US$ Million)
        • 13.1.2.2.6 Argentina Radiopharmaceutical Theranostics Market, by Application, 2019-2028 (US$ Million)
        • 13.1.2.2.7 Argentina Radiopharmaceutical Theranostics Market, by Indication, 2019-2028 (US$ Million)
        • 13.1.2.2.8 Argentina Radiopharmaceutical Theranostics Market, by End User, 2019-2028 (US$ Million)
      • 13.1.2.3 Rest of South & Central America: Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
        • 13.1.2.3.1 Overview
        • 13.1.2.3.2 Rest of South & Central America Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
        • 13.1.2.3.3 Rest of South & Central America Radiopharmaceutical Theranostics Market, by Product Type, 2019-2028 (US$ Million)
        • 13.1.2.3.4 Rest of South & Central America Radiopharmaceutical Theranostics Market, by Radioisotope, 2019-2028 (US$ Million)
        • 13.1.2.3.5 Rest of South & Central America Radiopharmaceutical Theranostics Market, by Source, 2019-2028 (US$ Million)
        • 13.1.2.3.6 Rest of South & Central America Radiopharmaceutical Theranostics Market, by Application, 2019-2028 (US$ Million)
        • 13.1.2.3.7 Rest of South & Central America Radiopharmaceutical Theranostics Market, by Indication, 2019-2028 (US$ Million)
        • 13.1.2.3.8 Rest of South & Central America Radiopharmaceutical Theranostics Market, by End User, 2019-2028 (US$ Million)

14. Radiopharmaceutical Theranostics Market - Industry Landscape

  • 14.1 Overview
  • 14.2 Growth Strategies in the Radiopharmaceutical Theranostics Market
  • 14.3 Inorganic Growth Strategies
    • 14.3.1 Overview
  • 14.4 Organic Growth Strategies
    • 14.4.1 Overview

15. Company Profiles

  • 15.1 Bayer AG
    • 15.1.1 Key Facts
    • 15.1.2 Business Description
    • 15.1.3 Products and Services
    • 15.1.4 Financial Overview
    • 15.1.5 SWOT Analysis
    • 15.1.6 Key Developments
  • 15.2 Curium
    • 15.2.1 Key Facts
    • 15.2.2 Business Description
    • 15.2.3 Products and Services
    • 15.2.4 Financial Overview
    • 15.2.5 SWOT Analysis
    • 15.2.6 Key Developments
  • 15.3 Telix Pharmaceuticals Ltd.
    • 15.3.1 Key Facts
    • 15.3.2 Business Description
    • 15.3.3 Products and Services
    • 15.3.4 Financial Overview
    • 15.3.5 SWOT Analysis
    • 15.3.6 Key Developments
  • 15.4 Siemens Healthineers AG
    • 15.4.1 Key Facts
    • 15.4.2 Business Description
    • 15.4.3 Products and Services
    • 15.4.4 Financial Overview
    • 15.4.5 SWOT Analysis
    • 15.4.6 Key Developments

16. Appendix

  • 16.1 About The Insight Partners
  • 16.2 Glossary of Terms

List Of Tables

  • Table 1. Brazil Radiopharmaceutical Theranostics Market, by Product type - Revenue and Forecast to 2028 (US$ Million)
  • Table 2. Brazil Radiopharmaceutical Theranostics Market, by Radioisotope - Revenue and Forecast to 2028 (US$ Million)
  • Table 3. Brazil Radiopharmaceutical Theranostics Market, by Source - Revenue and Forecast to 2028 (US$ Million)
  • Table 4. Brazil Radiopharmaceutical Theranostics Market, by Application - Revenue and Forecast to 2028 (US$ Million)
  • Table 5. Brazil Radiopharmaceutical Theranostics Market, by Indication - Revenue and Forecast to 2028 (US$ Million)
  • Table 6. Brazil Radiopharmaceutical Theranostics Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 7. Argentina Radiopharmaceutical Theranostics Market, by Product Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 8. Argentina Radiopharmaceutical Theranostics Market, by Radioisotope - Revenue and Forecast to 2028 (US$ Million)
  • Table 9. Argentina Radiopharmaceutical Theranostics Market, by Source - Revenue and Forecast to 2028 (US$ Million)
  • Table 10. Argentina Radiopharmaceutical Theranostics Market, by Application - Revenue and Forecast to 2028 (US$ Million)
  • Table 11. Argentina Radiopharmaceutical Theranostics Market, by Indication - Revenue and Forecast to 2028 (US$ Million)
  • Table 12. Argentina Radiopharmaceutical Theranostics Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 13. Rest of South & Central America Radiopharmaceutical Theranostics Market, by Product Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 14. Rest of South & Central America Radiopharmaceutical Theranostics Market, by Radioisotope - Revenue and Forecast to 2028 (US$ Million)
  • Table 15. Rest of South & Central America Radiopharmaceutical Theranostics Market, by Source - Revenue and Forecast to 2028 (US$ Million)
  • Table 16. Rest of South & Central America Radiopharmaceutical Theranostics Market, by Application - Revenue and Forecast to 2028 (US$ Million)
  • Table 17. Rest of South & Central America Radiopharmaceutical Theranostics Market, by Indication - Revenue and Forecast to 2028 (US$ Million)
  • Table 18. Rest of South & Central America Radiopharmaceutical Theranostics Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 19. Recent Inorganic Growth Strategies in the Radiopharmaceutical Theranostics Market
  • Table 20. Recent Organic Growth Strategies in the Radiopharmaceutical Theranostics Market
  • Table 21. Glossary of Terms

List Of Figures

  • Figure 1. South & Central America Radiopharmaceutical Theranostics Market Segmentation
  • Figure 2. South & Central America Radiopharmaceutical Theranostics Market, by Country
  • Figure 3. South & Central America Radiopharmaceutical Theranostics Market Overview
  • Figure 4. Positron Emission Tomography (PET) Tracers Segment Held Largest Share of Product Type Segment in Radiopharmaceutical Theranostics Market
  • Figure 5. Brazil Expected to Show Remarkable Growth During Forecast Period
  • Figure 6. South & Central America: PEST Analysis
  • Figure 7. South & Central America Experts' Opinion
  • Figure 8. South & Central America Radiopharmaceutical Theranostics Market: Impact Analysis of Drivers and Restraints
  • Figure 9. South & Central America Radiopharmaceutical Theranostics Market - Revenue Forecast and Analysis - 2020-2028
  • Figure 10. South & Central America Radiopharmaceutical Theranostics Market Revenue Share, by Product Type 2021 & 2028 (%)
  • Figure 11. Positron Emission Tomography (PET) Tracers: South & Central America Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 12. Beta Emitters: South & Central America Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 13. Alpha Emitters: South & Central America Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 14. South & Central America Radiopharmaceutical Theranostics Market, by Radioisotope, 2021 & 2028 (%)
  • Figure 15. Technetium-99: South & Central America Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 16. Gallium-68: South & Central America Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 17. Iodine-131: South & Central America Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 18. Iodine-123: South & Central America Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 19. Fluorine-18 (18F): South & Central America Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 20. Yttrium 90 (Y-90): South & Central America Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 21. Lutetium (LU) 177: South & Central America Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 22. Copper (CU) 67: South & Central America Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 23. Copper (CU) 64: South & Central America Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 24. Others: South & Central America Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 25. South & Central America Radiopharmaceutical Theranostics Market, by Source, 2021 & 2028 (%)
  • Figure 26. Nuclear Reactors: South & Central America Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 27. Cyclotrons: South & Central America Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 28. South & Central America Radiopharmaceutical Theranostics Market, by Application, 2021 & 2028 (%)
  • Figure 29. Targeted Therapeutics (Rx): South & Central America Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 30. Companion Diagnostics (CDx): South & Central America Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 31. South & Central America Radiopharmaceutical Theranostics Market, by Indication, 2021 & 2028 (%)
  • Figure 32. Oncology: South & Central America Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 33. Neurology: South & Central America Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 34. Cardiology: South & Central America Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 35. Others: South & Central America Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 36. South & Central America Radiopharmaceutical Theranostics Market, by End User, 2021 & 2028 (%)
  • Figure 37. Hospitals: South & Central America Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 38. Diagnostic Imaging Centers: South & Central America Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 39. Academic & Research Institutes: South & Central America Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 40. Others: South & Central America Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 41. South & Central America: Radiopharmaceutical Theranostics Market, by Key Country - Revenue (2021) (US$ Million)
  • Figure 42. South & Central America: Radiopharmaceutical Theranostics Market, by Country, 2021 & 2028 (%)
  • Figure 43. Brazil Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 44. Argentina Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 45. Rest of South & Central America Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 46. Growth Strategies in the Radiopharmaceutical Theranostics Market